Journal article
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial
JAMA : the journal of the American Medical Association, Vol.305(20), pp.2071-2079
05/25/2011
DOI: 10.1001/jama.2011.679
PMID: 21610239
Abstract
Idiopathic sudden sensorineural hearing loss has been treated with oral corticosteroids for more than 30 years. Recently, many patients' symptoms have been managed with intratympanic steroid therapy. No satisfactory comparative effectiveness study to support this practice exists.
Details
- Title: Subtitle
- Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial
- Creators
- Steven D Rauch - Department of Otology and Laryngology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114, USA. steven_rauch@meei.harvard.eduChristopher F HalpinPatrick J AntonelliSeilesh BabuJohn P CareyBruce J GantzJoel A GoebelPaul E HammerschlagJeffrey P HarrisBrandon IsaacsonDaniel LeeChristopher J LinstromLorne S ParnesHelen ShiWilliam H SlatterySteven A TelianJeffrey T VrabecDomenic J Reda
- Resource Type
- Journal article
- Publication Details
- JAMA : the journal of the American Medical Association, Vol.305(20), pp.2071-2079
- DOI
- 10.1001/jama.2011.679
- PMID
- 21610239
- NLM abbreviation
- JAMA
- ISSN
- 0098-7484
- eISSN
- 1538-3598
- Publisher
- United States
- Grant note
- U01-DC006296 / NIDCD NIH HHS
- Language
- English
- Date published
- 05/25/2011
- Academic Unit
- Neurosurgery; Otolaryngology
- Record Identifier
- 9984006300602771
Metrics
36 Record Views